PTC Therapeutics, Inc. Gross Profit 2011–2025
PTC Therapeutics, Inc. reported $294.85M of gross profit for fiscal 2019. That was 17.0% higher than fiscal 2018. Compared with fiscal 2017, the change was +55.3%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | — | — | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | — | — | — |
| FY 2019 | $294.85M | 96.0% | +17.0% |
| FY 2018 | $252.06M | 95.2% | +32.8% |
| FY 2017 | $189.81M | 97.6% | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
Source: PTC Therapeutics, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PTCT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
PTC Therapeutics, Inc. reported $294.85M of gross profit for fiscal 2019. That was 17.0% higher than fiscal 2018. Compared with fiscal 2017, the change was +55.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s gross profit?
PTC Therapeutics, Inc. (PTCT) reported gross profit of $294.85M for fiscal year 2019, per its SEC filings.
How has PTC Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, PTCT's gross profit grew at roughly 3.2% per year (compound annual rate), from $189.81M to $294.85M.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.